OS Therapies Inc
SEC CIK 1795091 · OSTX · last insider filing 2026-05-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Romness Paul A. | Director · President and CEO | filed 2024 - 2026 |
| Jarry Olivier Roger | Director | filed 2024 - 2026 |
| Ciccio John | Director | filed 2024 - 2026 |
| Search Theodore F. | Director | filed 2024 - 2026 |
| Mckean-Dieser Avril Suzette | Director | filed 2024 - 2026 |
| Galzahr Karim | Director | filed 2025 - 2026 |
| Goddard Colin | Director | filed 2024 - 2025 |
| Borg Joacim | Director | filed 2024 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Petit Robert | See Remarks | filed 2024 - 2026 |
| Acevedo Christopher P. | Chief Financial Officer | filed 2024 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.